Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial-Reference-Cited by-同舟云学术

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

Published:2021-08 Issue:8 Volume:5 Page:e617
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Döhner Hartmut,Symeonidis Argiris,Deeren Dries,Demeter Judit,Sanz Miguel A.,Anagnostopoulos Achilles,Esteve Jordi,Fiedler Walter,Porkka Kimmo,Kim Hee-Je,Lee Je-Hwan,Usuki Kensuke,D'Ardia Stefano,Won Jung Chul,Salamero Olga,Horst Heinz-August,Recher Christian,Rousselot Philippe,Sandhu Irwindeep,Theunissen Koen,Thol Felicitas,Döhner Konstanze,Teleanu Veronica,DeAngelo Daniel J.,Naoe Tomoki,Sekeres Mikkael A.,Belsack Valerie,Ge Miaomiao,Taube Tillmann,Ottmann Oliver G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference26 articles.

1. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.;Juliusson;Blood,2009

2. Acute myeloid leukemia.;Döhner;N Engl J Med,2015

3. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.;Burnett;Cancer,2007

4. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.;Döhner;Blood,2017

5. PLK-1 targeted inhibitors and their potential against tumorigenesis.;Kumar;Biomed Res Int,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectroscopic study on volasertib: Highly stable complexes with albumin and encapsulation into alginate/montmorillonite bionanocomposites;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-12

2. Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia;Annals of Hematology;2024-08-29

3. Targeting polo-like kinase 1: advancements and future directions in anti-cancer drug discovery;Expert Opinion on Drug Discovery;2024-07-29

4. Progress with polo-like kinase (PLK) inhibitors: a patent review (2018–present);Expert Opinion on Therapeutic Patents;2024-07-15

5. New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives;Journal of Medicinal Chemistry;2024-07-02